SCM
BIIB icon

Sandler Capital Management’s Biogen BIIB Stock Holding History

Sandler Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-13,000
Closed -$5.49M – 170
2015
Q1 		$5.49M Buy
+13,000
New +$5.12M 0.34% 118

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Sandler Capital Management's BIIB Position: Q2 2015 in Review

Sandler Capital Management sold out of Biogen (BIIB) in Q2 2015, closing a stake of 13,000 shares — an estimated $5.49M sold.

Sandler Capital Management first reported a position in BIIB in Q1 2015 and held it in 1 quarter. The position peaked at $5.49M in Q1 2015. 974 funds tracked by Wall St. Rank hold BIIB as of Q2 2015.

  • Sandler Capital Management reported no remaining Biogen position as of Q2 2015 after selling out during the quarter.
  • Sandler Capital Management sold 13,000 Biogen shares in Q2 2015, an estimated $5.49M.
  • Sandler Capital Management first reported a position in Biogen in Q1 2015 and held it in 1 quarter.
  • Sandler Capital Management's Biogen position peaked at $5.49M in Q1 2015.
  • 974 funds tracked by Wall St. Rank held Biogen as of Q2 2015.

Based on Sandler Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.